David W. Haas

机构：Meharry Medical College, Vanderbilt University Medical Center · ORCID：0000-0002-5813-1594

发表论文 338 篇 · 总被引 17658 次 · h-index 66

代表论文

• Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV (2024 · JAMA Cardiology · 被引 86)
• Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort (2024 · Pharmacogenetics and Genomics · 被引 9)
• Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa (2024 · British Journal of Clinical Pharmacology · 被引 9)
• A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial (2025 · The Lancet Infectious Diseases · 被引 5)
• Genetic polymorphisms and adverse reactions to antituberculosis therapy (2025 · Pharmacogenomics · 被引 4)
• Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis (2025 · Pharmacogenetics and Genomics · 被引 4)